Pricing Log in Create free account

AbCellera Biologics Inc. (ABCL) vs Edgewise Therapeutics, Inc. (EWTX)

AbCellera Biologics Inc. and Edgewise Therapeutics, Inc. are both Biotechnology companies. Edgewise Therapeutics, Inc. is the larger, with a market value of $4.2B against $3.6B — 1.2× the size. Edgewise Therapeutics, Inc. has the higher net margin (0.00% vs −248.8%) and the higher return on invested capital (0.00% vs −42.5%). Across the 13 metrics below, Edgewise Therapeutics, Inc. leads on 7 and AbCellera Biologics Inc. on 6.

Valuation

Metric ABCL EWTX Biotechnology median
P/E n/m n/m 10.26
P/S 51.95 n/m 9.18
P/B 3.84 9.39 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 43.46 n/m 8.98
Earnings yield (4.80%) (4.73%) (34.89%)
Free cash flow yield (3.57%) (3.77%) (24.52%)

Profitability

Metric ABCL EWTX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (340.25%) 0.00% 0.00%
Net margin (248.82%) 0.00% 0.00%
Free cash flow margin (180.84%) 0.00% 0.00%
Return on equity (17.30%) (38.03%) (50.12%)
Return on assets (12.15%) (36.09%) (45.60%)
Return on invested capital (42.52%) 0.00% 0.00%

Growth

Metric ABCL EWTX Biotechnology median
Revenue growth (TTM) 101.29% — 6.26%
EPS growth (last fiscal year) 10.91% (12.41%) 29.88%
Revenue growth, 5-year CAGR (20.27%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABCL EWTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.77 16.24 4.89
Net debt to EBITDA 2.97 2.69 1.01

Dividend

Metric ABCL EWTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABCL EWTX Biotechnology median
Market cap 3.61b 4.22b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack